Dr. Tsai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Magnolia Dr, SRB-3
Tampa, FL 33612Phone+1 813-745-4864
Summary
- I am a board-certified dermatologist and dermatopathologist leading a NIH funded research program focused on cutaneous squamous cell carcinoma, signaling pathways in melanoma and responses to therapy, and biomarker development for skin cancer risk and prediction of therapeutic responses. I lead a new translational research effort to address unmet needs in high-risk non-melanoma skin cancers within the Melanoma and Skin Cancer Center of Excellence.
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2007 - 2008
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2004 - 2007
- Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
- Harvard Medical SchoolClass of 2003
- Massachusetts Institute of TechnologyPhD, Biology, 1996 - 2001
- Yale CollegeBS, Applied Physic, 1989 - 1993
Certifications & Licensure
- FL State Medical License 2016 - 2026
- TX State Medical License 2008 - 2018
- MA State Medical License 2007 - 2014
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- AACR Landon Foundation Cancer Prevention Award American Association for Cancer Research, 2013
- Chief Resident, Dermatology 2007
- Medical Scientist Training Program National Institues of Health, 2003
Publications & Presentations
PubMed
- PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability.Neel Jasani, Xiaonan Xu, Benjamin Posorske, Yumi Kim, Kaizhen Wang
Cancer Research. 2025-01-15 - Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.Thomas Kuilman, Deborah S Schrikkema, Jules Gadiot, Raquel Gomez-Eerland, Laura Bies
Nature Communications. 2025-01-14 - spatialGE is a User-Friendly Web Application that Facilitates Spatial Transcriptomics Data Analysis.Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon, Alex C Soupir, Inna Smalley
Cancer Research. 2024-12-05
Press Mentions
- Reviewers' List December 2020August 12th, 2020
- Reviewers' List December 2019August 23rd, 2019
Professional Memberships
- Fellow
- Society for Investigative DermatologyMember
- Member
- Member
External Links
- Moffitthttps://moffitt.org/research-science/researchers/kenneth-tsai/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: